Resultados da busca - Hao-Rui Shen

EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis por Wei-Ting Wang, Jing-Ran Guo, Li Wang, Jia-Zhu Wu, Hao-Rui Shen, Yi-Lin Kong, Yi Xia, Jian-Yong Li, Jin-Hua Liang, Wei Xu

Obter o texto integral

Dual-utility ctDNA in diffuse large B-cell lymphoma: integrated genotyping unveils minimal residual disease dynamics and subtype-specific clonal evolution por Jin-Hua Liang, Yi-Fan Wu, Si-Ying Pan, Kai-Xin Du, Yi-Lun Ji, Liu-Qing Zhu, Hao-Rui Shen, Jia-Zhu Wu, Hua Yin, Yue Li, Li Wang, Jian-Yong Li, Wei Xu

Obter o texto integral

Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy por Wei Hua, Jie Liu, Yue Li, Hua Yin, Hao‐Rui Shen, Jia‐Zhu Wu, Yi‐Lin Kong, Bi‐Hui Pan, Jun‐Heng Liang, Li Wang, Jian‐Yong Li, Rui Gao, Jin‐Hua Liang, Wei Xu

Obter o texto integral

SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma por Zi‐Wen Duan, Wei‐Ting Wang, Yan Wang, Rong Wang, Wei Hua, Chun‐Yu Shang, Rui Gao, Hao‐Rui Shen, Yue Li, Jia‐Zhu Wu, Hua Yin, Li Wang, Jian‐Yong Li, Wei Xu, Jin‐Hua Liang

Obter o texto integral

Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms por Kai-Xin Du, Yi-Fan Wu, Wei Hua, Zi-Wen Duan, Rui Gao, Jun-Heng Liang, Yue Li, Hua Yin, Jia-Zhu Wu, Hao-Rui Shen, Li Wang, Yang Shao, Jian-Yong Li, Jin-Hua Liang, Wei Xu

Obter o texto integral

Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial por Jin-Hua Liang, Tong-Yao Xing, Wei-Ying Gu, Hua Yin, Qing-Shu Zeng, Kai-Xin Du, Luthuli Sibusiso, Jia-Zhu Wu, Yue Li, Fei Wang, Rui Gao, Jian-Yong Li, Hao-Rui Shen, Li Wang, Wei Xu

Obter o texto integral

Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial por Hao-Rui Shen, Jia-Zhu Wu, Hua Yin, Kai-Xin Du, Luthuli Sibusiso, Yi-Fan Wu, Wei Hua, Yue Li, Yi-Lin Kong, Xin-Yu Zhang, Rui Gao, Jian-Yong Li, Li Wang, Jin-Hua Liang, Wei Xu

Obter o texto integral